Scholars Central

PerspectivePublished 15 Jul 2016

Exploring standards for industrializing human induced pluripotent stem cells

Authors: Hidemasa Kato, Keiko Hiraki-Kamon, Masamitsu Eitoku, Hidenori Kiyosawa, Cindy Neeley & Yasushi Okazaki

Pharmaceutical Bioprocessing

Volume 3 · Issue 3 · Pages 199–213

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Popular belief assumes that human pluripotent cells can now be obtained in any lab or company by induced pluripotent stem (iPS) cell reprogramming. However, the difficulties in robustly producing human iPS-derived cells that are fit for drug discovery are becoming increasingly apparent. This is because we still have not come up with a strict definition of pluripotency. Our attempts at prospectively identifying differentiation-defective human iPS cells using teratoma assays or marker expression have clearly failed to date. Here, we will revisit how conventional pluripotency tests have failed in evaluating iPS cells adequately for drug discovery and emphasize two aspects of developmental transitions (what we call here a cell’s chronological value and the segregation of factors as it differentiates) to elucidate inherent problems with our current understanding of human iPS cells. Finally, we challenge the field by presenting our perspective on distinguishing good human iPS cells from bad ones.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pharmaceutical Bioprocessing.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Bioprocessing
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Hidemasa Kato”
  • BylineArticles whose byline prints “Keiko Hiraki-Kamon”
  • BylineArticles whose byline prints “Masamitsu Eitoku”
  • BylineArticles whose byline prints “Hidenori Kiyosawa”
  • BylineArticles whose byline prints “Cindy Neeley & Yasushi Okazaki”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels